Stella E Panos1, Charles H Hinkin1, Elyse J Singer2, April D Thames1, Sapna M Patel1, Janet S Sinsheimer3, A C Del Re4, Benjamin B Gelman5, Susan Morgello6, David J Moore7, Andrew J Levine2. 1. Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, David Geffen School of Medicine ; VA Greater Los Angeles Healthcare System. 2. National Neurological AIDS Bank, UCLA Department of Neurology. 3. Departments of Biomathematics and Human Genetics, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA. 4. Department of Psychiatry, Stanford University, Menlo Park, CA. 5. Department of Pathology, University of Texas Medical Branch, Galveston, TX. 6. Departments of Neurology, Neuroscience, and Pathology, The Mount Sinai School of Medicine, New York, NY. 7. Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, CA, USA.
Abstract
BACKGROUND: The apolipoprotein-E (APOE) ε4 allele is a risk factor for vascular dementia and Alzheimer's disease. Recent studies are equivocal with regards to whether or not the ε4 allele confers increased risk for the development of human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND), but suggest that age and/or disease severity may be modulating factors. The aim of this study was to assess the interactions and contributions of APOE genotype, age, and HIV disease severity as risk factors for HAND in HIV-infected adults. METHODS: Participants were 259 HIV-positive individuals who underwent APOE genotyping, a standardized neurological evaluation, a comprehensive neuropsychological evaluation, and laboratory testing. RESULTS: Older ε4 carriers showed a higher frequency of HAND compared with age-matched non-ε4 carriers. Analysis by discrete neurocognitive domain revealed that advanced age modulated the effect of the ε4 allele, such that older ε4 allele carriers showed reduced executive functioning and information processing speed. Exploratory analyses assessing the relationship between ε4 and disease severity in the overall sample revealed that disease severity modulated the effect of the ε4 allele on cognition. Lower absolute CD4+ cell count among ε4 allele carriers was associated with poorer working memory ability. CONCLUSION: Advancing age and degree of immunosuppression may influence the association between APOE ε4 allele status and HAND. These two factors need to be taken into account in future research.
BACKGROUND: The apolipoprotein-E (APOE) ε4 allele is a risk factor for vascular dementia and Alzheimer's disease. Recent studies are equivocal with regards to whether or not the ε4 allele confers increased risk for the development of human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND), but suggest that age and/or disease severity may be modulating factors. The aim of this study was to assess the interactions and contributions of APOE genotype, age, and HIV disease severity as risk factors for HAND in HIV-infected adults. METHODS:Participants were 259 HIV-positive individuals who underwent APOE genotyping, a standardized neurological evaluation, a comprehensive neuropsychological evaluation, and laboratory testing. RESULTS: Older ε4 carriers showed a higher frequency of HAND compared with age-matched non-ε4 carriers. Analysis by discrete neurocognitive domain revealed that advanced age modulated the effect of the ε4 allele, such that older ε4 allele carriers showed reduced executive functioning and information processing speed. Exploratory analyses assessing the relationship between ε4 and disease severity in the overall sample revealed that disease severity modulated the effect of the ε4 allele on cognition. Lower absolute CD4+ cell count among ε4 allele carriers was associated with poorer working memory ability. CONCLUSION: Advancing age and degree of immunosuppression may influence the association between APOE ε4 allele status and HAND. These two factors need to be taken into account in future research.
Entities:
Keywords:
aging; apolipoprotein-E; human immunodeficiency virus; neurocognition
Authors: Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman Journal: N Engl J Med Date: 2009-07-16 Impact factor: 91.245
Authors: Mark L Ettenhofer; Charles H Hinkin; Steven A Castellon; Ramani Durvasula; Jodi Ullman; Mona Lam; Hector Myers; Matthew J Wright; Jessica Foley Journal: Am J Geriatr Psychiatry Date: 2009-04 Impact factor: 4.105
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: S Smieszek; P Jia; D C Samuels; Z Zhao; J Barnholtz-Sloan; H Kaur; S Letendre; R Ellis; D R Franklin; T Hulgan; A Kallianpur; W S Bush Journal: Mitochondrion Date: 2018-07-17 Impact factor: 4.160
Authors: James T Becker; Jeremy J Martinson; Sudhir Penugonda; Lawrence Kingsley; Samantha Molsberry; Sandra Reynolds; Aaron Aronow; Karl Goodkin; Andrew Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor Journal: J Neurovirol Date: 2014-11-12 Impact factor: 2.643
Authors: Christine Fennema-Notestine; Tricia A Thornton-Wells; Todd Hulgan; Scott Letendre; Ronald J Ellis; Donald R Franklin; Albert M Anderson; Robert K Heaton; Cinnamon S Bloss; Igor Grant; Asha R Kallianpur Journal: Brain Imaging Behav Date: 2020-10 Impact factor: 3.978
Authors: Sarah A Cooley; Robert H Paul; Christine Fennema-Notestine; Erin E Morgan; Florin Vaida; Qianqian Deng; Jie Ashley Chen; Scott Letendre; Ronald Ellis; David B Clifford; Christina M Marra; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; David M Simpson; Susan Morgello; Igor Grant; Beau M Ances Journal: J Neurovirol Date: 2016-03-28 Impact factor: 2.643
Authors: Lauren A Wendelken; Neda Jahanshad; Howard J Rosen; Edgar Busovaca; Isabel Allen; Giovanni Coppola; Collin Adams; Katherine P Rankin; Benedetta Milanini; Katherine Clifford; Kevin Wojta; Talia M Nir; Boris A Gutman; Paul M Thompson; Victor Valcour Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: Fan Nils Yang; Margarita Bronshteyn; Sarah A Flowers; Matthew Dawson; Princy Kumar; George William Rebeck; Raymond Scott Turner; David J Moore; Ronald J Ellis; Xiong Jiang Journal: AIDS Date: 2021-04-01 Impact factor: 4.177